Boston Scientific Corp. (B1SX34R) 뉴스

Ackman May get more shares to lower his 2.30 average but he’s not going to shoot himself in the foot. The price will hit 34+ minimum.

That’s rich coming from the tard who thinks Ackman has option contracts on an OTC stock. Quit acting like you have the faintest clue about trading LOL

lol... clever 😂

WTAF

https://cdn.bsky.app/img/feed_thumbnail/plain/did:plc:t6ubj2wlhc34awzcymh3qpur/bafkreifydgvfhmlytbutvdt5csuqonpccd2dli2gtvq2ahjnreguq2g3gy@jpeg

Simple answer. It’s because their sole focus should be on fundamentally increasing the value of the company regardless of current market price/sentiment. . Predictions are just that. Too many factors to list that can affect what one thinks the price may be at some specified time in the future. It’s

You don't even know what a rights offering us nor have you participated in one. Moron

And we have the potential to grow revenue another 10-fold within a couple of years. Half the time it took to move from 7M to 70M.

Say goodbye to the 3.50 wall. 😎🤑😎🤑😎

https://www.nytimes.com/2025/01/02/opinion/democrats-donald-trump-economy.html?unlocked_article_code=1.mU4.xnRc.wWBotJMLt6g9&smid=nytcore-ios-share&referringSource=articleShare

VERY good! The criteria to be approved as a seller on Amazon (business, not private) are serious; being accepted is a big step for us! The potential for the company is huge, as Amazon's customer base is international.
It is a household name not only in the U. S.

Pleases SHARE T

CramerTrade2016

And all caps mean nothing.

No rights offering will cover his 11% and 10% holdings of FnF Coms. Face it, you have never been right and now you look the fool.

Let's say in a couple months I managed to get a peek at an internal Treasury memo saying that they intend to write off the seniors. If I ignore insider trading laws and such, I would strongly consider selling a good chunk of my juniors to buy commons because the risk/reward would be drastically diff

BIEL scammers out in full force.😎

The expanding clinical application as well as together with indication of CRISPR/Cas9, mounting preclinical and clinical trials, rise in technological advancement, presences of key players like Intellia Therapeutics, CRISPR Therapeutics, Editas Medicine, TransCode Therapeutics and many more, combina

Happy New Year BB!!. Based on your bottoming call on ADTX, I did some extensive DD and accumulated 1,000,000 shares over the last few sessions with an overall cost basis of .1912. Thanks for the heads up on this one.

I believe they will be announcing a collaboration with a deep pocket

You are in the right direction.
This is GOLDEN 🚀🔥

As of November 18, 2024, the issuer had 2,369,037,729 shares of its common stock issued and outstanding

Outstanding Shares 5,469,037,729 01/02/2025
Restricted 3,457,147,781 01/02/2025
Unrestricted 2,011,889,948 01/02/2025

On December 30, 2024, Two Hands Co

ECRO
FTCO
KLYG
VALE

MITQ, SD, SGMA, CMI.V

MITQ, SD, SGMA, CMI.V

To make long story short this was RM nearly two years now. Go dig and learn. Do your DD for your own sake. For Crying out loud!

+14.71% on 1.3M shares, just below average. Definitely still no ATM. $318M cash & equivalents and $1.2B backlog. Current market cap approximately $210M. Sacramento project nearing completion, PORTHOS running ahead of schedule, modules being delivered summer 2025. Exxonmobil plan to build 1,500M

I told you all ackman is not to be trusted he will profit more because he will be able to put in more capital through a generous rights offering.

Impressive day on GRCU